People have been anticipating the demise of radiologists for years, speculating that AI will soon be interpreting imaging results with the precision of a seasoned veteran.

Researchers have developed a new AI model that could be a game-changer in the treatment of blindness and vision loss.

The Mayo Clinic’s flagship campus in Minnesota is installing an AI-powered patient triage and prediction platform.

As researchers have turned to AI for battling COVID-19, raising hopes and making headlines, the shortcomings of the studies have drawn the ire of numerous statistics experts.

A molecular diagnostics company is working with a genetic-health AI startup at breathing virtual life into a cognitive chatbot tasked with assisting individuals who may be at risk of hereditary cancer.

The company, Nevada-based A-Medicare, is the brainchild of Italy-born actor, filmmaker and entrepreneur Enzo Zelocchi. 

A deep learning model has achieved human-level proficiency in three of five exercises, accurately categorizing verbal expressions from more than 33,000 talk-therapy patients who underwent their sessions online.

In the heat of the present pandemic, the findings are fascinating even when they’re not startling—although in at least one instance they’re both.